Key facts
- It has raised $500K; the latest was Merger/Acquisition in Apr 2026.
- Status: Acquired/Merged.
- ·Watchlist + deal alerts for Galen AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Galen AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Galen AI
Developer of an AI-powered personal healthcare companion platform intended to enhance patient support and medical decision-making. The company's platform integrates medical records from institutions, synchronizes data from wearable devices, delivers automated clinical summaries, and provides personalized care plans with educational resources and reminders, enabling healthcare providers to improve care coordination, health literacy, and outcomes through real-time, data-driven insights.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2025
- Employees
- 2
- Website
- galenai.com/
- Ownership
- Acquired/Merged
Galen AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Galen AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Galen AI in its N-PORT filings yet. We sweep new filings monthly.